Charles Walters
Psychiatry · Dayton, OHNPI 1598745556
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 333 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 24.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,975 and has fallen 82.3% since, to $350 in 2024.
Across 333 payments — averaging $16.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Vanda Pharmaceuticals Inc.$918
- Otsuka America Pharmaceutical, Inc.$898
- Johnson & Johnson$797
- Teva Pharmaceuticals USA, Inc.$451
- Sunovion Pharmaceuticals Inc.$312
- plus $871 from 13 others
What the payments were for
- Food & beverage$5,588100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 129 | $1,340 |
| Vanda Pharmaceuticals Inc. | 32 | $918 |
| Otsuka America Pharmaceutical, Inc. | 61 | $898 |
| Johnson & Johnson | 28 | $797 |
| Teva Pharmaceuticals USA, Inc. | 17 | $451 |
| Sunovion Pharmaceuticals Inc. | 14 | $312 |
| Alkermes, Inc. | 13 | $222 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $168 |
| Almatica Pharma LLC | 5 | $96 |
| Idorsia Pharmaceuticals US Inc | 5 | $93 |
| Neurocrine Biosciences, Inc. | 6 | $87 |
| Axsome Therapeutics, Inc. | 2 | $59 |
| Avanir Pharmaceuticals, Inc. | 4 | $51 |
| Jazz Pharmaceuticals Inc. | 1 | $22 |
| Noven Therapeutics, LLC | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Indivior Inc. | 1 | $13 |
| Bausch Health US, LLC | 1 | $13 |
| Lundbeck LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$254
- INVEGA SUSTENNA$126
- INVEGA TRINZA$126
- SPRAVATO$124
- LATUDA$121
- AUSTEDO$120
- ABILIFY MAINTENA$112
How this compares
$5,588 in reported general payments places this provider in the 85th percentile of 1,119 psychiatry providers in Ohio.
Other psychiatry in Dayton
- Amita PatelDayton$2.1M
- Otto DuenoDayton$74K
- Ramakrishna GollamudiDayton$21K
- Darshan SehbiDayton$19K
- Henry NasrallahCincinnati$3.8M
- Fred RomeoColumbus$2.3M
- Pradeep ManudhaneCanton$1.5M
- Michael SaribalasColumbus$1.2M
- Kevin WareColumbus$1.1M
- Binit ShahCleveland$913K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.